Latest Healthtech Startup Funding Rounds
Companies building technology for healthcare delivery, diagnosis, clinical workflows and patient access.
- Rounds
- 753 Jan 1 – Oct 25, 2026
- Disclosed funding
- $25.9B 612 disclosed amounts
- Median round
- $16M Of disclosed amounts
| Company | Amount | Round | Sector | Country | Investors | Announced |
|---|---|---|---|---|---|---|
| H H1Company profile Sells detailed information about doctors to pharma companies, hospital systems, and health insurers Sells detailed information about doctors to pharma companies, hospital systems, and health insurers | $40M | StrategicUndisclosed | Healthtech | United States | Investors | |
| CL Develops single-molecule PCR technology for genomics measurement | $26M | Series A | Healthtech, Biotech | United States | Investors | |
| T TriomicsCompany profile Building AI infrastructure to turn complex cancer records into structured intelligence Building AI infrastructure to turn complex cancer records into structured intelligence | $22M | Series B | Healthtech | United States | Investors | |
| S AI-native marketing agency accelerating pharma commercialization | $21M | Series A | Healthtech | United States | Investors | |
| P PsileraCompany profile Develops next-generation neuroplastogens and psychedelic therapies for neurological conditions Develops next-generation neuroplastogens and psychedelic therapies for neurological conditions | $8.8M | Seed+Seed | Healthtech, Biotech | United States | Investors Undisclosed | |
| EL Ember LifeSciencesCompany profile Reusable temperature-controlled shipping platform for pharmaceutical cold chain distribution Reusable temperature-controlled shipping platform for pharmaceutical cold chain distribution | $27M | Series A | Healthtech | United States | Investors | |
| ST Secretome TherapeuticsCompany profile Clinical-stage company developing neonatal cardiac progenitor cell therapies for Duchenne-associated cardiomyopathy Clinical-stage company developing neonatal cardiac progenitor cell therapies for Duchenne-associated cardiomyopathy | $30M | Series A | Healthtech, Biotech | United States | Investors | |
| CR Captive RadiologyCompany profile Provides turnkey diagnostic imaging and theranostic solutions to hospitals and physician groups Provides turnkey diagnostic imaging and theranostic solutions to hospitals and physician groups | Undisclosed | Growth | Healthtech | United States | Investors | |
| S SONDCompany profile Builds closed-loop in-ear earbuds that capture physiological signals and deliver real-time AI-guided sleep interventions Builds closed-loop in-ear earbuds that capture physiological signals and deliver real-time AI-guided sleep interventions | $7M | Seed | Healthtech | United States | Investors | |
| CH ClearNote HealthCompany profile Develops noninvasive blood-based early detection tests for pancreatic and ovarian cancers Develops noninvasive blood-based early detection tests for pancreatic and ovarian cancers | $52M | Series DSeries C+ | Healthtech, Biotech | United States | Investors |
Active investors in this selection
All investors →Ranked by rounds participated in · From Jan 1, 2026
- 1General Catalyst
Baba, Disha (formerly Curelink), Thatch
23rounds2led - 2Y Combinator (YC)
Vitalize, Angle Health, Metriport
21rounds0led - 3Alumni Ventures
MintNeuro, Evvy, Hopscotch Primary Care
13rounds0led - 4Andreessen Horowitz (a16z)
Sharp Performance, General Medicine, Devoted Health
12rounds2led - 5Khosla Ventures
Even Healthcare, Abby Care, Rightway
11rounds1led
Latest digests
Archive →Explore published rounds while the next edition is being prepared.